ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,478Medicare Part D Prescriptions Filled, Including Refills

Rank: 123 out of 1171

$594K Total Retail Price of All Prescriptions

Rank: 151 out of 1171

474 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,630 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 543 428 1 5
LEVOTHYROXINE SODIUM 499 415 2 4
LISINOPRIL 380 325 3 3
SIMVASTATIN 339 282 4 1
HYDROCODONE-ACETAMINOPHEN 304 241 S3 5 8
AMLODIPINE BESYLATE 295 279 6 2
METOPROLOL TARTRATE 291 243 7 11
FUROSEMIDE 268 227 8 6
LOSARTAN POTASSIUM 261 200 9 14
METOPROLOL SUCCINATE 256 216 10 17
METFORMIN HCL 236 179 11 7
ATENOLOL 210 173 12 15
POTASSIUM CHLORIDE 209 197 13 19
WARFARIN SODIUM 208 178 14 12
HYDROCHLOROTHIAZIDE 170 145 15 9
CITALOPRAM HBR 169 124 16 22
PRAVASTATIN SODIUM 166 162 17 13
GABAPENTIN 156 110 18 16
NEXIUM 155 137 19 25
ZOLPIDEM TARTRATE 142 105 20 21
ATORVASTATIN CALCIUM 132 115 21 10
ESCITALOPRAM OXALATE 116 87 22 69
SYNTHROID 108 106 23 48
DONEPEZIL HCL 107 107 24 24
MELOXICAM 102 94 25 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 91 25 26
SERTRALINE HCL 91 61 27 23
CRESTOR 89 89 28 27
CARVEDILOL 88 86 29 20
TRAZODONE HCL 88 82 29 37
ALLOPURINOL 88 80 29 31
PANTOPRAZOLE SODIUM 85 44 32 29
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 33 40
MIRTAZAPINE 74 69 34 50
DILTIAZEM 24HR CD 73 73 35 101
GLIPIZIDE ER 70 62 36 86
GLIPIZIDE XL 69 55 37 124
ALENDRONATE SODIUM 66 66 38 33
BYSTOLIC 65 65 39 96
METFORMIN HCL ER 65 64 39 52
DILTIAZEM 24HR ER 64 64 41 112
PAROXETINE HCL 64 39 41 62
IBUPROFEN 62 53 43 80
BENICAR 61 61 44 181
TAMSULOSIN HCL 60 53 45 28
TRIAMTERENE-HCTZ 60 55 45 58
LANTUS 59 34 47 46
PROAIR HFA 58 52 48 49
DIGOXIN 58 58 48 68
LEXAPRO 57 49 50 222
AMITRIPTYLINE HCL 56 53 R 51 74
DIOVAN 55 52 52 32
KLOR-CON M20 54 54 53 41
AZITHROMYCIN 54 42 53 43
LEVOFLOXACIN 54 39 53 105
KLOR-CON 10 53 48 56 126
SPIRIVA 53 49 56 57
NAMENDA 51 51 58 42
LANTUS SOLOSTAR 50 44 59 90
ZETIA 50 46 59 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.